CalciMedica, Historical Income Statement
| CALC Stock | 2.76 0.01 0.36% |
Historical analysis of CalciMedica, Common income statement accounts such as Selling General Administrative of 14.6 M, Other Operating Expenses of 24.9 M or Research Development of 16 M can show how well CalciMedica, Common Stock performed in making a profits. Evaluating CalciMedica, Common income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CalciMedica, Common's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining CalciMedica, Common Stock latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CalciMedica, Common Stock is a good buy for the upcoming year.
CalciMedica, |
About CalciMedica, Income Statement Analysis
CalciMedica, Common Stock Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CalciMedica, Common shareholders. The income statement also shows CalciMedica, investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
CalciMedica, Common Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of CalciMedica, Common Stock. It is also known as CalciMedica, Common overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Most accounts from CalciMedica, Common's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CalciMedica, Common Stock current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, CalciMedica, Common's Research Development is projected to decrease significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 24.9 M, whereas Depreciation And Amortization is forecasted to decline to about 55.1 K.
CalciMedica, Common income statement Correlations
Click cells to compare fundamentals
CalciMedica, Common Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CalciMedica, Common income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 303K | 395K | 519K | 52K | 58K | 55.1K | |
| Selling General Administrative | 6.9M | 8.9M | 17.0M | 19.1M | 22.2M | 14.6M | |
| Other Operating Expenses | 37.5M | 29.8M | 35.9M | 33.2M | 21.9M | 24.9M | |
| Operating Income | (37.5M) | (29.8M) | (35.9M) | (36.2M) | (21.9M) | (23.0M) | |
| Ebit | (37.5M) | (29.8M) | (35.9M) | (7.7M) | (34.2M) | (36.0M) | |
| Research Development | 30.6M | 21.0M | 18.9M | 14.1M | 12.4M | 16.0M | |
| Ebitda | (37.2M) | (29.4M) | (35.4M) | (7.6M) | (34.2M) | (35.9M) | |
| Total Operating Expenses | 37.5M | 29.8M | 35.9M | 33.2M | 21.8M | 24.9M | |
| Income Before Tax | (37.0M) | (27.5M) | (35.8M) | (35.6M) | (34.4M) | (36.1M) | |
| Total Other Income Expense Net | 72K | 2.2M | (1.4M) | 28.4M | (12.5M) | (11.9M) | |
| Net Income | (37.0M) | (27.5M) | (35.8M) | (35.6M) | (34.4M) | (36.1M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CalciMedica, Common Stock offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CalciMedica, Common's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Calcimedica, Common Stock Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Calcimedica, Common Stock Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CalciMedica, Common. If investors know CalciMedica, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CalciMedica, Common listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.11) | Return On Assets (0.65) | Return On Equity (0.84) |
The market value of CalciMedica, Common Stock is measured differently than its book value, which is the value of CalciMedica, that is recorded on the company's balance sheet. Investors also form their own opinion of CalciMedica, Common's value that differs from its market value or its book value, called intrinsic value, which is CalciMedica, Common's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CalciMedica, Common's market value can be influenced by many factors that don't directly affect CalciMedica, Common's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CalciMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if CalciMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CalciMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.